Anebulo Pharmaceuticals
ANEB
ANEB
13 hedge funds and large institutions have $14.2M invested in Anebulo Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$70.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.47K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$315 |
| 4 |
BlackRock
New York
|
+$278 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$21 |
Top Sellers
| 1 |
LA
LVW Advisors
Pittsford,
New York
|
-$1.93K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.17K |
| 3 |
JPMorgan Chase & Co
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
2L
1
22NW LP
Seattle,
Washington
| $10.4M | – | – | – |
|
|
LA
2
LVW Advisors
Pittsford,
New York
| $1.24M | -$1.93K | -1,000 | -0.2% |
|
|
NCM
3
Nantahala Capital Management
New Canaan,
Connecticut
| $986K | – | – | – |
|
4
Morgan Stanley
New York
| $770K | – | – | – |
|
|
IC
5
Ikarian Capital
Dallas,
Texas
| $305K | – | – | – |
|
|
6
Vanguard Group
Malvern,
Pennsylvania
| $297K | +$315 | +163 | +0.1% |
|
|
7
Geode Capital Management
Boston,
Massachusetts
| $169K | +$70.4K | +36,482 | +71% |
|
|
BFM
8
Boothbay Fund Management
New York
| $36.6K | – | – | – |
|
|
9
BlackRock
New York
| $7.54K | +$278 | +144 | +4% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $5.2K | -$1.17K | -606 | -18% |
|
|
11
UBS Group
Zurich,
Switzerland
| $1.47K | +$1.47K | +763 | New |
|
|
12
Bank of America
Charlotte,
North Carolina
| $147 | +$21 | +11 | +17% |
|
|
13
JPMorgan Chase & Co
New York
| $17 | -$2 | -1 | -10% |
|